The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Epilepsy · Drug Resistant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Xuanwu Hospital, Beijing, Beijing, Beijing Municipality, China
Contact: Study coordinator (Liankun Ren, MD) · renlk2022@outlook.com · +86 13681576621

Study leads

Liankun Ren, MD
Principal Investigator
Xuanwu Hospital, Beijing

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Electroclinical Correlation of Anxiety

Anxiety Disorder · Generalized Anxiety Disorder · Drug Resistant Epilepsy

Abroad (travel likely)Recruiting

Bordeaux, France

Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology

Drug Resistant Epilepsy · Magnetic Resonance Imaging · Electroencephalogram (EEG)

Abroad (travel likely)Recruiting

Xi'an, China

Understanding Ketamine's Dissociative Effects (KD Study)

Epilepsy

Abroad (travel likely)RecruitingPHASE1

Palo Alto, United States

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

KCNT1-Related Epilepsy

Abroad (travel likely)RecruitingPHASE1

Sydney, Australia